| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4003745 | American Journal of Ophthalmology | 2010 | 9 Pages |
Abstract
A single intravitreal dose of Sirna-027 up to 1600 μg/eye was well tolerated in patients with CNV resulting from neovascular AMD that had been refractory to other therapies. Stabilization or improvement in visual acuity and foveal thickness was observed. No dose-response or dose-limiting effects were noted.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Peter K. Kaiser, R.C. Andrew Symons, Syed Mahmood Shah, Edward J. Quinlan, Homayoun Tabandeh, Diana V. Do, Gail Reisen, Jennifer A. Lockridge, Brian Short, Roberto Guerciolini, Quan Dong Nguyen,